True. The prospects of the other subsidiaries (including CA) does not seem as good as it used to, but there is still some value; MEIJI, SJAP, HSA and HU are all profitable after all (at least in gross profits) and CA will generate nice profits post TRW-financing (although distributing shares in CA might not be relevant as long as CA only does business with TRW).
Unless CA gets some contracts besides TRW maybe MEIJI is the next candidate for COSO?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.